These Defensive Stocks Aren’t So Defensive Anymore — Investors Need to Wake Up

“Defensive” doesn’t mean “can’t drop.” Utilities, consumer staples, health care, REITs, and low-volatility funds can still get hit hard—especially when interest rates, regulation, and consumer behavior shift. Here’s how

“Defensive stocks” used to communicate a sort of “sleep well at night” vibe. But in today’s market, old labels can be dangerously misleading. A stock can sell critical widgets, pay a steady dividend, and get punched in the face by higher rates, policy shifts, a demon demand shock, or a stretched valuation.

The wake-up call isn’t that defensives are “bad”—it’s that few investors stress test defensives like stroking a seatbelt on takeoff when instead they’re just a different kind of risk to your downside. The sooner you start stress testing your “safe” holdings, the less likely you are to get surprised when the market regime changes.

TL;DR

• “Defensive” very often means lower beta/lower volatility, not “won’t fall.” (kiplinger.com)
• Utilities, REITs, and other high dividend areas can behave like “bond proxies” making them sensitive to interest rate moves. (lgt.com)
• Consumer staples can lose their luster, and so, all of a sudden, their edge is lost when bags of chips are traded down to private labels and volumes soften. (mckinsey.com)
• Health care outside of commodities freaks us out more than it should. The ‘defensive’ reputation of health care is now challenged by reimbursement and drug-pricing policy (and you all know the players by now). Medicare price negotiations under the IRA. Oh, no they didn’t ? Knocking us F… out. cms.gov
• Low-volatility ETFs become crowded and concentrated in a couple of defensives and sensitive sectors, “hidden” risk like oversized exposures. (spglobal.com)

What “defensive” really means (and what it never meant)

Most people use “defensive” to mean one of two things: 1) A business whose demand stays steadier in recessions (people still buy electricity, toothpaste and many medications) and/or 2) a stock (or fund) that historically moved less than the broad market (often measured by beta — market beta ≈ 1; “defensive” often implies below 1). (kiplinger.com)

Here’s the thing: a low-beta or stable-demand business is not low risk as an investment. As an equity holder you’re still subject to all the same risks — valuation risk, balance-sheet risk, policy risk, “the market realizing it overpaid for safety,” and so forth.

Why defensive stocks can stop acting defensive

Defensives tend to disappoint when investors decide that they’re protected from every kind of downturn when in fact they may only be protected from one scenario (a traditional recession) and vulnerable to others.

• Rate shock (higher yields): Dividend-heavy sectors may look less attractive versus bonds and long-duration cash flows become more economically sensitive to discounting (this is why “bond proxy” gets invoked so often). (lgt.com)
• Balance-sheet stress: Many traditional “boring” industries are capital intensive (utilities, telecom, real estate). As getting funded becomes harder, capital availability and associated refinancing costs can affect the earnings and dividend coverage.
• Policy and regulation: health care reimbursement, drug pricing rules, utility rate cases, real estate policy can all change the economics quickly. (cms.gov)
• Changes in consumer behavior: inflation and uncertainty may drive trade-down to private label, and “premium” brands in staples categories can get attacked rapidly.
• Crowding and concentration: The low vol and dividend related strategies tend to cluster toward the same sectors (utilities, staples, parts of health care), creating risk that “everyone exits the same door”. (mckinsey.com)

The usual suspects: “defensive” areas with very non-defensive risks

1) Utilities: stable demand, unstable outcomes

Utilities can be defensive on the demand side—customers don’t stop using electricity in a slowdown. But they can be non-defensive in terms of the valuation and financing side of a business, since they often exhibit long duration asset like traits with real debt and ongoing capex needs—hence why many folks describe them as “bond proxies”. (lgt.com)

What’s different now is that they are being pulled into big structural themes—grid modernization, electrification, fast-growing data-center demand—where there are more risks. More growth = good, but execution risk, level of capex and heightened political scrutiny on who pays for the network folding can all be risks.

• Data-centers are a real demand driver: The U.S. Department of Energy recently warned that data centers are estimated to have consumed about 4.4% of U.S. electricity in 2023 and are expected to reach 6.7%–12% by 2028. (energy.gov)
• Demand is rising globally too, the IEA’s initial impressions of their review on Energy and AI notes data-centers electricity use is rising rapidly, and geographically the ecosystem for AI powered systems and software is concentrated too. (iea.org)
• Capex + higher for longer rates = squeeze… More spending grows the rate base but funding and timing can matter, especially when rates are higher for longer. (deutschewealth.com)

2) Consumer staples: “pricing power” has limits

Consumer staples look defensive because people keep buying food, beverages, cleaning supplies, and personal care items. The problem is that staples stocks often trade at premiums when investors crowd into “safety,” and premium brands can get challenged when consumers become value-obsessed.

In the post-inflation era, a common pattern has been: price increases support revenue, but volumes weaken as households trade down or buy less. That’s not a theoretical risk—major consumer brands have publicly discussed volume pressure during inflationary periods. (axios.com)

Private label isn’t just a recession fad: McKinsey reported that 36% of consumers planned to buy more private label, and many consumers view private brands as equal or better quality. (mckinsey.com)

NielsenIQ has noted a long-running rise in private-label share and improving quality perceptions—meaning the competitive pressure can persist even after inflation cools. (nielseniq.com)

Tariffs and input costs can still matter: staples companies can face new cost shocks (and then have to decide whether to raise prices again and risk more trade-down). (apnews.com)

3) Health care: defensive… until policy gets involved

Health care demand can be resilient, but the sector has a unique “defensive trap”: policy and reimbursement can dominate fundamentals. In the U.S., the Inflation Reduction Act (IRA) established a Medicare drug price negotiation framework that could significantly impact certain drug makers over time—particularly for older, single-source drugs with high spending.

CMS announced negotiated prices for the first round of the Medicare Drug Price Negotiation Program (applicable to year 2026) CMS on cms.gov.

The Government Accountability Office (GAO) reported on the early implementation of these drug-pricing provisions, including guidance and oversight planning. files.gao.gov.

Explain what you can expect from the Medicare drug pricing negotiation program. Ed explains the scaling of the size of this program and its purpose. commonwealthfund.org. This doesn’t say “avoid health care,” suggests you don’t treat it as a pure macro hedge. A political headline, a court decision, or even new guidance cycle can matter as much (or more) as the earnings of the business.

4) REITs: rate sensitivity is real—but not simple

Real estate and REITs may be grouped with “defensive income.” But it’s more nuanced: REIT performance may depend on why rates are moving (growth vs. inflation vs. credit stress), property type fundamentals, lease structure, and balance sheet positioning.

Nareit has done some of this analysis, arguing that historically, REITs have posted positive total returns many times in both rising- and falling-rate periods. Here is the educational bit on “rates up = REITs down,” if you’ve been pitched it. reit.com.

5) Telecom & communications infrastructure: the debt problem

Traditional telecom is often viewed as defensive because it sells “must-have” connectivity and may pay dividends. But telecom and related infrastructure can be capex-heavy and debt-heavy—exactly the mix that can struggle when borrowing costs rise or competition heats up.

Higher-rate environments can weigh on highly levered communications models; even articles aimed at retail investors often flag debt load and rate sensitivity as key risks. (nasdaq.com)

Some professional/manager commentary highlights refinancing risk as a major driver of telecom-infrastructure equity volatility. (magellaninvestmentpartners.com)

The hidden issue: defensive ETFs can concentrate the same risks

Many investors outsource “defense” to low-volatility, minimum-volatility, dividend, or “quality income” ETFs. That can be reasonable—but you still need to understand what’s inside, because these strategies often tilt to similar sector exposures.

Index providers have shown that low-volatility constructions can produce notable sector skews (often toward utilities and consumer staples), and those skews can shift over time. (spglobal.com)

Even when a low-volatility ETF delivers lower beta over long windows, it can still have short periods where it behaves unexpectedly (for example, when its biggest sector bets are exactly the sectors getting repriced). Kiplinger’s discussion of low-volatility ETFs highlights both the intended lower market sensitivity and the common defensive-sector tilts. (kiplinger.com)

Table: what can break the “defensive” thesis?

The 15-minute “defensiveness audit” (for any stock or ETF)

1. Name the scenario you’re defending against. Recession? Sticky inflation? A rate spike? A policy shock? Different defensives help with different problems.
2. Check market defensiveness: look up beta and downside history across multiple windows (1-, 3-, 5-, 10-year if available). One number is not enough. (kiplinger.com)
3. Check valuation defensiveness: is it priced like a “safe haven”? If you pay a premium, you may be buying ‘defense’ that can evaporate when sentiment changes.
4. Check balance-sheet defensiveness: net debt/EBITDA, interest coverage, and a debt maturity ladder. ‘Defensive’ businesses can still be fragile if financing tightens.
5. Check dividend defensiveness: payout ratio (relative to free cash flow), not just yield. High yield can signal high risk.
6. Check rate sensitivity: compare the holding’s drawdowns during yield spikes (if it’s a ‘bond proxy’ candidate) vs. broad market drawdowns. (lgt.com)
7. Check customer behavior risk: for staples, watch volume trends and private-label pressure; for health care, watch utilization and reimbursement rules. (mckinsey.com)
8. Audit for policy/regulatory “headline risk”: which agencies, which key rules and cadence of decision-making affect the business? (CMS for Medicare pricing; state utility commissions for rates). (cms.gov)
9. Audit for concentration: using an ETF, what are the sector weights and top holdings? Low-volatility strategies can skew incredibly towards a couple sectors. (spglobal.com)
10. Size position based on audit. A stock can be ‘defensive-ish’ and still deserve a smaller weight if it risks asymmetrically to the downside.

Common mistakes investors make with defensive stocks

• “Getting the ‘recession’ hedge wrong when it’s a ‘rate’ hedge”.
• Blindly chasing yield without checking debt levels (dividends are paid after interest is due).
• Buying into sector labels/cute names, when leverage, market positions, and competitive factors vary widely across “defensive” names.
• Substituting ‘low vol equals low risk’ with no attention paid to crowded positioning and structural weakness. (spglobal.com)
• Neglecting consumer substitution risk in staples names (think private label, switching costs, etc). (mckinsey.com)
• Ignoring policy risk in health care because ‘people always need medicine’. (cms.gov)

Build defense at portfolio level rather than on investing in just “defensive” tickers

• If your goal is to reduce your downside exposure through a drawdown, then often you get a cleaner covering in that regard thinking in terms of building blocks instead of stereotypes.
• Diversification in combination that’s real (not five funds that all overweight the same two hardest hit sectors together).
• Would you have a cash plan/liquidity plan so your choices aren’t coerced to sell in drawdown?
• Interest-rate “matchmaking”: if rates are your primary risk, you may wish to assess your aggregated portfolio’s duration-like exposure across equities and fixed income (and not inadvertently double down on ‘bond proxies’). (lgt.com)
• Rebalancing rules you can follow. Defensive assets can turn expensive after a flight-to-safety episode; having a rule helps remove emotion from the equation.

How to verify (so you don’t invest on vibes)

1. For a stock: read risk factors and debt footnotes in the most recent 10-K/10-Q; double-check maturities and exposure (fixed vs floating) of salient debt.
2. For a sector ETF: check current sector weights; compare against the ETF’s top holdings; assess the methodology (does it cap sectors? does it modify to optimize volatility?). (spglobal.com)
3. For utilities: track capex plans and cadence of rate case filings; understand how (and when) returns are established.
4. For staples: if possible, look for known volume/price mix in the earnings release; what are private-label trends? indicators of consumers ‘trading down’? (mckinsey.com)
5. For health care: monitor updates from CMS and credible others explaining policy; can key products likely to be sensitive to negotiation timelines be identified? (cms.gov)
6. For REITs: compare/contrast average lease duration and debt maturity schedules; reaffirm property-type fundamentals for estimating rent growth, occupancy, new supply. (reit.com)

FAQ